文献速递甲状腺疾病

甲状腺乳头状癌腺叶切除术后最佳血清促甲状腺激素水平探讨

Optimal Serum Thyrotropin Level for Patients with Papillary Thyroid Carcinoma After Lobectomy.
PubMed 文献 · Thyroid · 2021-12-31

本研究纳入2000至2014年单中心2297例甲状腺乳头状癌腺叶切除术后患者,分析平均血清促甲状腺激素(TSH)与复发的关系。结果显示平均TSH与无复发生存率无显著关联,推荐术后维持正常TSH参考范围。

要点

  • 平均血清TSH水平与腺叶切除术后PTC复发无显著关联
  • 低危和中高危组中平均TSH均非复发独立预测因子
  • 推荐术后患者维持正常血清TSH参考范围

核心结论

  • 平均血清TSH水平与甲状腺乳头状癌腺叶切除术后复发无显著关联
  • 推荐术后患者维持正常血清TSH参考范围

研究设计与样本

  • 单中心回顾性队列研究,纳入2000年1月至2014年12月接受腺叶切除术的PTC患者
  • 共分析2297例患者,中位年龄42岁,女性1750例(76.2%)

主要发现

  • 平均TSH≤0.5 mU/L、0.6-2 mU/L、2.1-4 mU/L和>4 mU/L的患者分别占29.1%、50.6%、15.0%和5.3%
  • 全队列、低危组和中高危组中平均TSH与无复发生存率均无显著关联(调整P值分别为0.4737、0.9314、0.1859)
  • 中高危组中平均TSH 0.6-2 mU/L者与>4 mU/L者10年无复发生存率分别为84.4%和69.4%(log rank P=0.011)

关键数值与推荐

  • 血清TSH参考范围为0.5-4.0 mU/L
  • 平均TSH分组:≤0.5 mU/L、0.6-2 mU/L、2.1-4 mU/L、>4 mU/L

临床怎么用

  • 腺叶切除术后PTC患者无需将TSH抑制至低于正常范围,维持正常参考范围即可

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The optimal serum thyrotropin (TSH) level for postlobectomy papillary thyroid carcinoma (PTC) patients is unclear. The objective of this study was to examine the association of TSH and recurrence in postlobectomy patients. Methods: Patients who underwent lobectomy for PTC in a single tertiary hospital from January 2000 to December 2014 were enrolled. The mean TSH of a patient was calculated based on each serum TSH value during follow-up. The reference range of serum TSH was 0.5-4.0 mU/L. Univariate and multivariable analyses were performed with Cox proportional hazards models. Restricted cubic spline (RCS) functions were used to model relationships between mean TSH and recurrence-free survival (RFS). Results: A total of 2297 patients (median age 42 years; 1750 (76.2%) female) were analyzed. Mean TSH below (≤0.5mU/L), in the lower half (0.6-2 mU/L), in the upper half (2.1-4 mU/L), and above (>4 mU/L) the reference range were observed in 668 (29.1%), 1162 (50.6%), 345 (15.0%), and 122 (5.3%) patients, respectively. According to the Cox model and RCS, no association was observed between mean TSH and RFS in the whole cohort, low-risk group and intermediate- to high-risk groups (adjusted p = 0.4737, 0.9314, 0.1859, adjusted p for nonlinear = 0.4589, 0.8622, 0.3010). The only RFS difference observed in the stratified univariate analysis was between patients with mean TSH in the lower half (0.6-2 mU/L, n = 659) and above the reference range (>4 mU/L, n = 68) in the intermediate- to high-risk group (10-year RFS by Kaplan-Meier 84.4% vs. 69.4%, log rank p = 0.011). Conclusions: Mean serum TSH levels are not associated with recurrence. A normal TSH reference range is recommended for postlobectomy PTC patients.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Xu S, Huang Y, Huang H, et al. Optimal Serum Thyrotropin Level for Patients with Papillary Thyroid Carcinoma After Lobectomy. Thyroid. 2021. PMID: 34617446. doi:10.1089/thy.2021.0404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。